Subsequent Events (Details Narrative) - Pharmsynthez [Member] - USD ($) |
1 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Feb. 28, 2021 |
Jan. 23, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Related Party Transaction [Line Items] | |||||
| Proceeds from Collection of Notes Receivable | $ 25,000 | $ 25,000 | |||
| Co-Development Agreement [Member] | |||||
| Related Party Transaction [Line Items] | |||||
| Payment for Co-Development Agreement | $ 500,000 | ||||
| Note receivable interest rate | 10.00% | ||||
| Interest income | $ 48,000 | $ 51,000 | |||
| X | ||||||||||
- Definition Amount of interest and fee income from loans classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Note receivable interest rate No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|